Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-03-30 @ 2:36 AM
Study NCT ID:
NCT02628704
Status:
WITHDRAWN
Last Update Posted:
2023-01-26
First Post:
2015-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KCP-330-015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None